Dextran Gadolinium Complexes as Contrast Agents for Magnetic Resonance Imaging to Sentinel Lymph Nodes
- First Online:
The aim was to investigate three dextran gadolinium complexes Dextran-DTPA-Gd as the potential MRI contrast agents in lymphatic system.
Three dextran gadolinium complexes Dextran-DTPA-Gd containing differing amounts of Gd-DTPA were synthesized by the incorporation of Gd-DTPA to the hydroxyl groups of dextran. These dextran ligands and gadolinium complexes were characterized, and their properties in vitro and in vivo were also evaluated.
Dextran-DTPA-Gd demonstrated obviously higher relaxation effectiveness than that of Gd-DTPA. The result of in vitro cytotoxicity assay showed that these macromolecular ligands and their corresponding gadolinium complexes had low cytotoxicity to HeLa cells. Dextran-DTPA-Gd greatly enhanced the contrast of MR images of normal politeal lymph nodes and reactive hyperplasia of politeal lymph nodes in rabbits and provided prolonged duration in lymphatic system with lower injection doses than that of Gd-DTPA. However, Dextran-DTPA-Gd displayed low signal enhancements in MR images of politeal lymph nodes with VX2 carcinoma in rabbits during the detection time.
These dextran gadolinium complexes Dextran-DTPA-Gd can be taken up selectively by lymphatic system and showed the potential as MRI contrast agents in lymphatic system.
KEY WORDSmagnetic resonance imaging (MRI) contrast agents gadolinium complexes dextran politeal lymph nodes
- 6.Yan GP, Zhang JY, Zhou JX, Bottle SE, Yu XH, Wu JY, Li L. Targeted contrast agents for molecular imaging in magnetic resonance imaging (MRI). Recent Advances of Bioconjugate Chemistry in Molecular Imaging, (ISBN 978-81-0210-7), Chen XY. Ed., 2008;371–98, Chapter 19, Research Signpost, Kerala, India.Google Scholar
- 9.Liu ZY. Lymphatic basic theory research and clinical application. Beijing: Science; 2003. p. 132–41. ISBN ISBN 7-03-009996-6.Google Scholar
- 12.Misselwitz B, Platzek J, Raduchel B, Oellinger JJ, Weinmann HJ. Gadofluorine 8: initial experience with a new contrast medium for interstitial MR lymphography. Magn Reson Mater Phy. 1999;8:190–95.Google Scholar
- 15.Elste V, Wagner S, Taupitz M, Pfefferer D, Kresse M, Hamm B, et al. Magnetic resonance lymphography in rats: effects of muscular activity and hyperthermia on the lymph node uptake of intravenously injected superparamagnetic iron oxide particles. Acad Radiol. 1996;3:660–6.CrossRefPubMedGoogle Scholar
- 16.Hamm B, Taupitz M, Hussmann P, Wagner S, Wolf KJ. MR lymphography with iron oxide particles: dose-response studies and pulse sequence optimization in rabbits. Am J Roentgenol. 1992;158:183–90.Google Scholar
- 18.Wen J, Zhuo RX, Wang L. Aromatic DTPA-Bis(amide) gadolinium complexes as hepatobiliary contrast agents for magnetic resonance imaging. Chin J Magn Reson. 1998;15(3):217–21.Google Scholar
- 19.Van Beer BE, Gallez B, Pringot J. Contrast-enhanced MR imaging of the liver. Radiology. 1997;203:297–306.Google Scholar
- 30.Yan GP, Wang XY, Mei LL. Vitamin B6 as liver-targeting group in drug delivery. In: Elliot CM, editor. Vitamin B: new research. Hauppauge: Nova Science; 2008. p. 153–74.Google Scholar
- 34.Shi FQ. How to copy the disease model of animals. Yi Xue Dong Wu Shi Yan Fang Fa, 1990;226–232, Chapter 4, RenMing WeiSheng Press, Bejing, China.Google Scholar